Auto-inflammatory disorders
|
Immunodeficiency Main Page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ali Akram, M.B.B.S.[2], Anmol Pitliya, M.B.B.S. M.D.[3]
Overview
Classification
| Auto-inflammatory disorders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Recurrent inflammation | Systemic inflammation with urticaria rash | Others | Sterile inflammation (skin/bone/joints) | Type 1 Interferonopathies | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Familial Mediterranean Fever | Familial Cold Autoinflammatory Syndrome (CAPS) | CANDLE syndrome | Predominant on the bone/joints | Predominant on the skin | Aicardi-Goutieres syndrome | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mevalonate kinase deficiency | Muckle Wells syndrome | COPA defect | Pyogenic sterile arthritis, pyoderma gangrenosum, acne(PAPA) syndrome, hyperzincemia and hypercalprotectinemia | Blau syndrome | Spondyloenchondro-dysplasia with immune dysregulation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TNF receptor-associated periodic syndrome; TRAPS | Neonatal onset multisystem inflammatory disease | NLRC4-MAS(Macrophage activating syndrome) | Chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anemia | CAMPS | STING-associated vasculopathy, infantile onset | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PLAID (PLCg2 associated antibody deficiency and immune dysregulation), or APLAID | DIRA (Deficiency of the interleukin 1 receptor antagonist) | DITRA | ADA2 deficiency | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NLRP1 deficiency | Cherubism | ADAM17 deficiency | XL reticulate pigmentary disorder | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| A20 haploinsufficiency | SLC29A3 mutation | USP18 deficiency | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Otulipenia/ORAS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AP153 deficiency | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Familial Mediterranean Fever
- Autosomal recessive (AR) transmission.
- It is caused by mutation in the pyrin gene (MEFV) on chromosome 16.
- Patients present with recurrent fever and attacks of peritonitis.
- Attacks are self-limiting, and require analgesia and non-steroidal anti-inflammatory drugs (such as diclofenac)[1]
- Colchicine has also proved useful in reducing painful attacks.[2]
For detailed information about Familial mediterranean fever, click here Familial mediterranean fever
Mevalonate kinase deficiency (Hyper IgD syndrome)
- Autosomal recessive(AR) transmission.
- It is caused by homozygous or compound heterozygous mutation in the gene encoding mevalonate kinase (MVK) on chromosome 12.
- Patients present with cervical adenopathy, headache, arthralgia and diarrhea.
- Laboratory findings include leukocytosis with high IgD levels.
TNF receptor-associated periodic syndrome
- Autosomal dominant (AD) transmission.
- It is caused by heterozygous mutation in the tumor necrosis factor receptor-1 gene (TNFRSF1A) on chromosome 12.[3]
- Patients present with recurrent attacks of fever, abdominal pain, tender skin lesions, and myalgia.[4]
- Etanercept has proven successful as treatment in a case of a young Danish child.
Familial Cold Autoinflammatory Syndrome (CAPS)
- Autosomal dominant (AD) transmission.
- It is caused by heterozygous mutation in the NLRP3 gene on chromosome 1.
- Patients present with maculopapular rash, fever, chills and arthralgias after exposure to cold temperature.
- For detailed information about Familial Cold Autoinflammatory Syndrome, click here Familial cold urticaria
Muckle Wells Syndrome (CAPS)
- Autosomal dominant (AD) transmission.
- It is caused by heterozygous mutation in the NLRP3 gene on chromosome 1.
- Patients present with skin rashes, arthralgias, and fever along with sensorineural deafness and renal amyloidosis.[6]
References
- ↑ A. Livneh & P. Langevitz (2000). "Diagnostic and treatment concerns in familial Mediterranean fever". Bailliere's best practice & research. Clinical rheumatology. 14 (3): 477–498. doi:10.1053/berh.2000.0089. PMID 10985982. Unknown parameter
|month=ignored (help) - ↑ S. E. Goldfinger (1972). "Colchicine for familial Mediterranean fever". The New England journal of medicine. 287 (25): 1302. doi:10.1056/NEJM197212212872514. PMID 4636899. Unknown parameter
|month=ignored (help) - ↑ M. F. McDermott, B. W. Ogunkolade, E. M. McDermott, L. C. Jones, Y. Wan, K. A. Quane, J. McCarthy, M. Phelan, M. G. Molloy, R. J. Powell, C. I. Amos & G. A. Hitman (1998). "Linkage of familial Hibernian fever to chromosome 12p13". American journal of human genetics. 62 (6): 1446–1451. doi:10.1086/301886. PMID 9585614. Unknown parameter
|month=ignored (help) - ↑ L. M. Williamson, D. Hull, R. Mehta, W. G. Reeves, B. H. Robinson & P. J. Toghill (1982). "Familial Hibernian fever". The Quarterly journal of medicine. 51 (204): 469–480. PMID 7156325.
- ↑ Heike Weyhreter, Marianne Schwartz, Tim D. Kristensen, Niels H. Valerius & Anders Paerregaard (2003). "A new mutation causing autosomal dominant periodic fever syndrome in a Danish family". The Journal of pediatrics. 142 (2): 191–193. doi:10.1067/mpd.2003.15. PMID 12584543. Unknown parameter
|month=ignored (help) - ↑ Catherine Dode, Nathalie Le Du, Laurence Cuisset, Frank Letourneur, Jean-Marie Berthelot, Gerard Vaudour, Alain Meyrier, Richard A. Watts, David G. I. Scott, Anne Nicholls, Brigitte Granel, Camille Frances, Francois Garcier, Patrick Edery, Serge Boulinguez, Jean-Paul Domergues, Marc Delpech & Gilles Grateau (2002). "New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes". American journal of human genetics. 70 (6): 1498–1506. PMID 11992256. Unknown parameter
|month=ignored (help)